{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:32:28Z","timestamp":1792211548379,"version":"4.4.0"},"reference-count":269,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":599,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jtct.2021.06.001","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T13:37:17Z","timestamp":1623332237000},"page":"817-835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"title":["National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report"],"prefix":"10.1016","volume":"27","author":[{"given":"Daniel","family":"Wolff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedran","family":"Radojcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lafyatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Resat","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel K.","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Shing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Sheshadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey D.E.","family":"Cuvelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Holler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon R.","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Jenq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan M.","family":"Hanash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jacobsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca D.","family":"Santomasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Steven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghui Katie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Dietrich-Ntoukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Saban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ervina","family":"Bilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Penack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Cowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegard T.","family":"Greinix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Sarantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Socie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Pidala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie L.","family":"Kitko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Couriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk R.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Paczesny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.06.001_bib0001","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.bbmt.2016.06.020","article-title":"Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study","volume":"22","author":"Grube","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0002","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/bmt.2013.70","article-title":"Comorbidity burden in patients with chronic GVHD","volume":"48","author":"Wood","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.02.034","article-title":"The future of chronic graft-versus-host disease: introduction to the 2020 National Institutes of Health Consensus Development Project Reports","author":"Pavletic","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2021.06.001_bib0004","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1182\/blood-2012-10-464198","article-title":"Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease","volume":"121","author":"Inamoto","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0005","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","article-title":"Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease","volume":"118","author":"Martires","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0006","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/bmt.2014.244","article-title":"Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)","volume":"50","author":"Detrait","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0007","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.bbmt.2014.07.001","article-title":"Incidence, risk factors, and long-term outcomes of sclerotic graft-versus-host disease after allogeneic hematopoietic cell transplantation","volume":"20","author":"Uhm","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0008","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/bmt.2016.158","article-title":"High prevalence of small- and large-fiber neuropathy in a prospective cohort of patients with moderate to severe chronic GvHD","volume":"51","author":"Bilic","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0009","doi-asserted-by":"crossref","first-page":"e44922","DOI":"10.1371\/journal.pone.0044922","article-title":"Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease","volume":"7","author":"Kraus","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2021.06.001_bib0010","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood-2016-05-715342","article-title":"Genetic risk factors for sclerotic graft-versus-host disease","volume":"128","author":"Inamoto","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0011","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/TP.0b013e3182497561","article-title":"Distinct oligoclonal T cells are associated with graft versus host disease after stem-cell transplantation","volume":"93","author":"Berrie","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2021.06.001_bib0012","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bmt.2015.133","article-title":"Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients","volume":"50","author":"Yew","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0013","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood-2013-07-514372","article-title":"Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease","volume":"123","author":"Bruggen","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0014","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1182\/blood-2009-11-256495","article-title":"Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma","volume":"116","author":"Hill","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clim.2017.05.013","article-title":"Increased proportions of functionally impaired regulatory T cell subsets in systemic sclerosis","volume":"184","author":"Ugor","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0016","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood-2016-02-702852","article-title":"Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease","volume":"128","author":"Koreth","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0017","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood-2015-10-672345","article-title":"Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD","volume":"127","author":"Alho","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0018","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.06.001_bib0019","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/blood-2007-01-071043","article-title":"Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease","volume":"110","author":"Svegliati","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0020","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1182\/blood-2017-08-801001","article-title":"Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease","volume":"130","author":"Wang","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0021","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1182\/blood-2011-03-341693","article-title":"A phase 1 study of imatinib for corticosteroid-dependent\/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies","volume":"118","author":"Chen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0022","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00432-013-1451-z","article-title":"Lack of association of platelet-derived growth factor (PDGF) receptor autoantibodies and severity of chronic graft-versus-host disease (GvHD)","volume":"139","author":"Spies-Weisshart","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0023","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/1078-0432.CCR-15-1443","article-title":"A randomized phase II crossover study of imatinib or rituximab for cutaneous sclerosis after hematopoietic cell transplantation","volume":"22","author":"Arai","year":"2016","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.jtct.2021.06.001_bib0024","doi-asserted-by":"crossref","first-page":"eaas9944","DOI":"10.1126\/sciadv.aas9944","article-title":"BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance","volume":"4","author":"Matsushita","year":"2018","journal-title":"Sci Adv"},{"key":"10.1016\/j.jtct.2021.06.001_bib0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jdermsci.2019.11.012","article-title":"Transcriptome landscape of myeloid cells in human skin reveals diversity, rare populations and putative DC progenitors","volume":"97","author":"Xue","year":"2020","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jtct.2021.06.001_bib0026","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1172\/JCI75935","article-title":"CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease","volume":"124","author":"Alexander","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2021.06.001_bib0027","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2017-01-758854","article-title":"Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-beta production","volume":"129","author":"Du","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0028","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1182\/blood-2017-04-779934","article-title":"Vitamin A-coupled liposomes containing siRNA against HSP47 ameliorate skin fibrosis in chronic graft-versus-host disease","volume":"131","author":"Yamakawa","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0029","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.163.10.5693","article-title":"Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma","volume":"163","author":"McCormick","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0030","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/blood-2005-01-0062","article-title":"TGF-beta in allogeneic stem cell transplantation: friend or foe?","volume":"106","author":"Banovic","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0031","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1172\/JCI90593","article-title":"Cytokine mediators of chronic graft-versus-host disease","volume":"127","author":"MacDonald","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2021.06.001_bib0032","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/cbin.10788","article-title":"M2 macrophages induce EMT through the TGF-\u03b2\/Smad2 signaling pathway","volume":"41","author":"Zhu","year":"2017","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jtct.2021.06.001_bib0033","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0034","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/modpathol.2010.48","article-title":"CD20, AIF-1, and TGF-beta in graft-versus-host disease: a study of mRNA expression in histologically matched skin biopsies","volume":"23","author":"Wu","year":"2010","journal-title":"Modern Pathol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0035","doi-asserted-by":"crossref","first-page":"CR322","DOI":"10.12659\/MSM.881804","article-title":"The kinetics of mRNA transforming growth factor beta1 expression and its serum concentration in graft-versus-host disease after allogeneic hemopoietic stem cell transplantation for myeloid leukemias","volume":"17","author":"Kyrcz-Krzemien","year":"2011","journal-title":"Med Sci Monitor"},{"key":"10.1016\/j.jtct.2021.06.001_bib0036","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/blood-2005-01-0062","article-title":"TGF-\u03b2 in allogeneic stem cell transplantation: friend or foe?","volume":"106","author":"Banovic","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0037","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/art.27220","article-title":"A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis","volume":"62","author":"Farina","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtct.2021.06.001_bib0038","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.4049\/jimmunol.1601054","article-title":"Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease","volume":"197","author":"Hakim","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0039","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2021.06.001_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/art.41668","article-title":"Tocilizumab Prevents Progression of Early Systemic Sclerosis Associated Interstitial Lung Disease","author":"Roofeh","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0041","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00277-020-03968-w","article-title":"IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis","volume":"99","author":"Kattner","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0042","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/ard.2010.134742","article-title":"Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis","volume":"70","author":"Dees","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2021.06.001_bib0043","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/art.30254","article-title":"Inhibition of notch signaling prevents experimental fibrosis and induces regression of established fibrosis","volume":"63","author":"Dees","year":"2011","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.jtct.2021.06.001_bib0044","article-title":"Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease","author":"Zhang","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0045","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1182\/blood-2012-01-403428","article-title":"Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease","volume":"120","author":"Zerr","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0046","first-page":"305","article-title":"Hedgehog blockade in the treatment of steroid-refractory sclerodermatous chronic graft-versus-host disease","volume":"54","author":"Radojcic","year":"2019","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2021.06.001_bib0047","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/bloodadvances.2017011239","article-title":"Phase 1 study of the Hedgehog pathway inhibitor sonidegib for steroid-refractory chronic graft-versus-host disease","volume":"1","author":"DeFilipp","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2021.06.001_bib0048","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1182\/blood.V128.22.805.805","article-title":"Notch signaling mediated by Dll1\/4 notch ligands controls the pathogenesis of both multi-organ system non-sclerodermatous and sclerodermatous chronic graft-versus-host disease","volume":"128","author":"Radojcic","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107477","article-title":"The therapeutic potential of second and third generation CB1R antagonists","volume":"208","author":"Cinar","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jtct.2021.06.001_bib0050","article-title":"Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft versus host disease","author":"Yuan","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0051","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.2020004871","article-title":"Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease","volume":"137","author":"Yuan","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/art.41294","article-title":"Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with systemic sclerosis","author":"Spiera","year":"2020","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.jtct.2021.06.001_bib0053","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1182\/blood.2020006892","article-title":"A randomized phase-2 trial of pomalidomide in subjects failing prior therapy of chronic graft-versus-host disease","volume":"137","author":"Curtis","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0054","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1468-3083.2003.00516.x","article-title":"Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography","volume":"17","author":"Gottl\u00f6ber","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0055","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archdermatol.2009.78","article-title":"Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease","volume":"145","author":"Clark","year":"2009","journal-title":"Arch Dermatol"},{"issue":"Suppl 113","key":"10.1016\/j.jtct.2021.06.001_bib0056","first-page":"146","article-title":"Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I\/II biomarker trial","volume":"36","author":"Mantero","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0057","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.jid.2017.06.032","article-title":"Inhibition of beta-catenin signaling in the skin rescues cutaneous adipogenesis in systemic sclerosis: a randomized, double-blind, placebo-controlled trial of C-82","volume":"137","author":"Lafyatis","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0058","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1002\/art.39287","article-title":"A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis","volume":"67","author":"Rice","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0059","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1172\/JCI77958","article-title":"Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients","volume":"125","author":"Rice","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2021.06.001_bib0060","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2019-125986","article-title":"KD025 for patients with chronic graft-versus-host disease (cGVHD)\u2014long-term follow-up of a phase 2a study (KD025-208)","volume":"134","author":"Jagasia","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0061","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1182\/blood-2017-04-779934","article-title":"Vitamin A\u2013coupled liposomes containing siRNA against HSP47 ameliorate skin fibrosis in chronic graft-versus-host disease","volume":"131","author":"Yamakawa","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0062","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/17425247.2019.1645119","article-title":"Site-specific drug delivery in the skin for the localized treatment of skin diseases","volume":"16","author":"Chen","year":"2019","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.jtct.2021.06.001_bib0063","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jtct.2021.06.001_bib0064","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/annrheumdis-2013-204221","article-title":"Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability","volume":"73","author":"Distler","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2021.06.001_bib0065","doi-asserted-by":"crossref","first-page":"eaax5851","DOI":"10.1126\/sciadv.aax5851","article-title":"MIBI-TOF: a multiplexed imaging platform relates cellular phenotypes and tissue structure","volume":"5","author":"Keren","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.jtct.2021.06.001_bib0066","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1083-8791(03)00242-8","article-title":"Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes","volume":"9","author":"Dudek","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0067","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.bbmt.2015.10.018","article-title":"Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation","volume":"22","author":"Arora","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0068","first-page":"51","article-title":"Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation","author":"Bergeron","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtct.2021.06.001_bib0069","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbmt.2010.11.018","article-title":"Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation","volume":"17","author":"Au","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0070","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/ppul.20908","article-title":"Acceptability and repeatability of spirometry in children using updated ATS\/ERS criteria","volume":"43","author":"Loeb","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0071","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1086\/504268","article-title":"Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses","volume":"193","author":"Erard","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jtct.2021.06.001_bib0072","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.bbmt.2018.11.022","article-title":"Pulmonary impairment after respiratory viral infections is associated with high mortality in allogeneic hematopoietic cell transplant recipients","volume":"25","author":"Sheshadri","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0073","article-title":"Early post-transplantation spirometry is associated with the development of bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation","author":"Jamani","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0074","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1513\/AnnalsATS.201604-262OC","article-title":"Lung function trajectory in bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplant","volume":"13","author":"Cheng","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jtct.2021.06.001_bib0075","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1164\/rccm.201707-1368OC","article-title":"Depletion of airway submucosal glands and TP63(+)KRT5(+) basal cells in obliterative bronchiolitis","volume":"197","author":"Swatek","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtct.2021.06.001_bib0076","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cell.2020.03.047","article-title":"Regenerative metaplastic clones in COPD lung drive inflammation and fibrosis","volume":"181","author":"Rao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jtct.2021.06.001_bib0077","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1172\/JCI65570","article-title":"Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease","volume":"123","author":"Byers","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2021.06.001_bib0078","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2006.01586.x","article-title":"Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells","volume":"7","author":"Vanaudenaerde","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0079","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1182\/blood-2014-03-562231","article-title":"Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans","volume":"123","author":"Flynn","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0080","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2011-07-364414","article-title":"Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans","volume":"119","author":"Srinivasan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0081","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2012-06-435008","article-title":"CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome","volume":"121","author":"Kuzmina","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30405-7","article-title":"Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study","author":"Combs","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jtct.2021.06.001_bib0083","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/bmt.2012.241","article-title":"Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis","volume":"48","author":"Bergeron","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0084","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bbmt.2013.03.017","article-title":"Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"19","author":"Holbro","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0085","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/his.13697","article-title":"Lung histopathology of non-infectious pulmonary complications after allogeneic haematopoietic stem cell transplantation","volume":"73","author":"Meignin","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.jtct.2021.06.001_bib0086","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1164\/rccm.201501-0174OC","article-title":"Longitudinal forced vital capacity monitoring as a prognostic adjunct after lung transplantation","volume":"192","author":"Belloli","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtct.2021.06.001_bib0087","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1164\/rccm.201306-1155OC","article-title":"Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction","volume":"189","author":"Todd","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtct.2021.06.001_bib0088","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.healun.2011.01.712","article-title":"Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction","volume":"30","author":"Sato","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0089","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.healun.2019.03.008","article-title":"Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome-A consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Glanville","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0090","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.chest.2020.02.076","article-title":"Machine learning algorithms to differentiate among pulmonary complications after hematopoietic cell transplant","volume":"158","author":"Sharifi","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jtct.2021.06.001_bib0091","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1183\/13993003.01121-2016","article-title":"Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation","volume":"48","author":"Greer","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtct.2021.06.001_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.03.033","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report [e-pub ahead of print April 9, 2021]","author":"Kitko","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2021.06.001_bib0093","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1164\/rccm.201410-1818OC","article-title":"Budesonide\/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation","volume":"191","author":"Bergeron","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtct.2021.06.001_bib0094","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbmt.2015.10.009","article-title":"Fluticasone, azithromycin, and montelukast treatment for new-onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation","volume":"22","author":"Williams","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.2017.9938","article-title":"Effect of azithromycin on airflow decline-free survival after allogeneic hematopoietic stem cell transplant: the ALLOZITHRO Randomized Clinical Trial","volume":"318","author":"Bergeron","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2021.06.001_bib0096","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbmt.2019.10.025","article-title":"Azithromycin use and increased cancer risk among patients with bronchiolitis obliterans after hematopoietic cell transplantation","volume":"26","author":"Cheng","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0097","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.bbmt.2018.04.012","article-title":"Extracorporeal photopheresis improves survival in hematopoietic cell transplant patients with bronchiolitis obliterans syndrome without significantly impacting measured pulmonary functions","volume":"24","author":"Hefazi","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0098","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bbmt.2012.01.017","article-title":"Pulmonary rehabilitation for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"18","author":"Tran","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0099","article-title":"Comprehensive pulmonary rehabilitation in patients with bronchiolitis obliterans syndrome: a case series","volume":"31","author":"Choi","year":"2020","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.jtct.2021.06.001_bib0100","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00167-2019","article-title":"A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation","volume":"5","author":"Iacono","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jtct.2021.06.001_bib0101","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1182\/blood-2016-11-752444","article-title":"Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells","volume":"129","author":"Du","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0102","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1111\/ajt.15814","article-title":"Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"20","author":"Cheng","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0103","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.acra.2018.01.013","article-title":"Machine learning algorithms utilizing quantitative CT features may predict eventual onset of bronchiolitis obliterans syndrome after lung transplantation","volume":"25","author":"Barbosa","year":"2018","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0104","first-page":"53","article-title":"Xenon-129 MRI detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry","author":"Walkup","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtct.2021.06.001_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0106","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","article-title":"Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report","volume":"21","author":"Lee","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0107","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bbmt.2013.02.001","article-title":"Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study","volume":"19","author":"Pidala","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0108","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3324\/haematol.2014.109611","article-title":"Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease","volume":"99","author":"Inamoto","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2021.06.001_bib0109","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3324\/haematol.2011.055186","article-title":"Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study","volume":"97","author":"Pidala","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2021.06.001_bib0110","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bbmt.2013.01.018","article-title":"Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers","volume":"19","author":"Wolff","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0111","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.seminhematol.2011.10.006","article-title":"Gastrointestinal, hepatobiliary, pancreatic, and iron-related diseases in long-term survivors of allogeneic hematopoietic cell transplantation","volume":"49","author":"Kida","year":"2012","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0112","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","article-title":"NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report","volume":"21","author":"Shulman","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0113","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00428-015-1803-y","article-title":"Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility","volume":"467","author":"Kreft","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jtct.2021.06.001_bib0114","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bbmt.2015.12.027","article-title":"Graft-versus-host disease after hla-matched sibling bone marrow or peripheral blood stem cell transplantation: comparison of North American Caucasian and Japanese Populations","volume":"22","author":"Kanda","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0115","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3324\/haematol.2016.149427","article-title":"Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups","volume":"101","author":"Inamoto","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2021.06.001_bib0116","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/bloodadvances.2019000386","article-title":"Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients","volume":"3","author":"Inamoto","year":"2019","journal-title":"Blood advances"},{"key":"10.1016\/j.jtct.2021.06.001_bib0117","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2019003369","article-title":"Microbe-derived short chain fatty acids butyrate and propionate are associated with protection from chronic GVHD","author":"Markey","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0118","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1182\/bloodadvances.2019000362","article-title":"Butyrogenic bacteria after acute graft-versus-host disease (GVHD) are associated with the development of steroid-refractory GVHD","volume":"3","author":"Golob","year":"2019","journal-title":"Blood advances"},{"key":"10.1016\/j.jtct.2021.06.001_bib0119","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1182\/blood.2019000216","article-title":"Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria","volume":"134","author":"Cuvelier","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0120","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0046-8177(86)80135-6","article-title":"Diffuse intestinal ulceration after marrow transplantation: a clinicopathologic study of 13 patients","volume":"17","author":"Spencer","year":"1986","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0121","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.humpath.2017.08.034","article-title":"Small bowel stenosis: a manifestation of chronic graft-versus-host disease in children?","volume":"72","author":"Tordjman","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0122","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nature06196","article-title":"Identification of stem cells in small intestine and colon by marker gene Lgr5","volume":"449","author":"Barker","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jtct.2021.06.001_bib0123","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20101559","article-title":"The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells","volume":"208","author":"Takashima","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtct.2021.06.001_bib0124","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1084\/jem.20170418","article-title":"R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host disease","volume":"214","author":"Hayase","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtct.2021.06.001_bib0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","article-title":"Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease","volume":"37","author":"Hanash","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jtct.2021.06.001_bib0126","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nature16460","article-title":"Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration","volume":"528","author":"Lindemans","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jtct.2021.06.001_bib0127","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1182\/blood-2011-12-401166","article-title":"Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of alpha-defensins","volume":"120","author":"Eriguchi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0128","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.06.003","article-title":"T cell recruitment to the intestinal stem cell compartment drives immune-mediated intestinal damage after allogeneic transplantation","volume":"51","author":"Fu","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jtct.2021.06.001_bib0129","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aay8556","article-title":"T cell-derived interferon-gamma programs stem cell death in immune-mediated intestinal damage","volume":"4","author":"Takashima","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0130","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/blood.2019003186","article-title":"Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE\/PBMTC 1202 studies","volume":"135","author":"Schultz","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0131","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbmt.2017.12.772","article-title":"Late gastrointestinal complications of allogeneic hematopoietic stem cell transplantation in adults","volume":"24","author":"Sung","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0132","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/bbmt.2003.49999","article-title":"Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study","volume":"9","author":"Akpek","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0133","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hon.2446","article-title":"Confocal endomicroscopy in diagnosis of intestinal chronic graft-versus-host disease","volume":"36","author":"Rieger","year":"2018","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0134","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/ajcp\/aqw050","article-title":"Histopathology of graft-vs-host disease of gastrointestinal tract and liver: an update","volume":"145","author":"Salomao","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0135","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbmt.2014.03.020","article-title":"Late-onset colitis after cord blood transplantation is consistent with graft-versus-host disease: results of a blinded histopathological review","volume":"20","author":"Milano","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0136","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/bmt.2013.44","article-title":"Evaluating the association between histological manifestations of cord colitis syndrome with GVHD","volume":"48","author":"Shimoji","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0137","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41409-017-0017-0","article-title":"Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0138","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1182\/blood-2011-08-375006","article-title":"Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease","volume":"118","author":"Ferrara","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0139","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.jtct.2021.06.001_bib0140","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.3389\/fimmu.2018.03179","article-title":"Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD","volume":"9","author":"Kohler","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0141","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","article-title":"The biology of chronic graft-versus-host disease: a task force report from the national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease","volume":"23","author":"Cooke","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0142","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jtos.2019.03.010","article-title":"Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: Implications for novel biomarkers and therapeutic strategies","volume":"17","author":"An","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtct.2021.06.001_bib0143","first-page":"111","article-title":"A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD","volume":"42","author":"Ogawa","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtct.2021.06.001_bib0144","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/bjo.83.10.1125","article-title":"Dry eye after haematopoietic stem cell transplantation","volume":"83","author":"Ogawa","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0145","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/bmt.2015.187","article-title":"Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation","volume":"50","author":"Na","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0146","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/ICO.0000000000000340","article-title":"Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation","volume":"34","author":"Shikari","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.jtct.2021.06.001_bib0147","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.bbmt.2015.05.020","article-title":"Impact of ocular chronic graft-versus-host disease on quality of life","volume":"21","author":"Sun","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0148","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.ophtha.2015.04.011","article-title":"Vision-related quality of life in patients with ocular graft-versus-host disease","volume":"122","author":"Saboo","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtct.2021.06.001_bib0149","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/IIO.0000000000000167","article-title":"Current approaches to treatment of ocular graft-versus-host disease","volume":"57","author":"Tung","year":"2017","journal-title":"International ophthalmology clinics"},{"key":"10.1016\/j.jtct.2021.06.001_bib0150","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/ICO.0000000000001109","article-title":"Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group diagnostic criteria as a chronic ocular GVHD-specific metric","volume":"36","author":"Rapoport","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.jtct.2021.06.001_bib0151","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.survophthal.2012.08.004","article-title":"Ocular graft-versus-host disease: a review","volume":"58","author":"Shikari","year":"2013","journal-title":"Survey of ophthalmology"},{"key":"10.1016\/j.jtct.2021.06.001_bib0152","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jtos.2019.10.005","article-title":"Corneal higher-order aberrations in eyes with chronic ocular graft-versus-host disease","volume":"18","author":"Shimizu","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtct.2021.06.001_bib0153","first-page":"2533","article-title":"Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy","volume":"17","author":"Ban","year":"2011","journal-title":"Mol Vis"},{"key":"10.1016\/j.jtct.2021.06.001_bib0154","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/bmt.2015.72","article-title":"Meibography and meibomian gland measurements in ocular graft-versus-host disease","volume":"50","author":"Engel","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0155","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41409-020-0824-6","article-title":"Adverse environmental conditions are a risk factor for ocular GvHD after allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Steven","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0156","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/ACI.0b013e328357b4b9","article-title":"Ocular graft-versus-host disease","volume":"12","author":"Hessen","year":"2012","journal-title":"Current opinion in allergy and clinical immunology"},{"key":"10.1016\/j.jtct.2021.06.001_bib0157","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0161-6420(99)00720-4","article-title":"Ocular findings in allogeneic stem cell transplantation without total body irradiation","volume":"106","author":"Kerty","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtct.2021.06.001_bib0158","first-page":"351","article-title":"Ocular graft versus host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations","volume":"8","author":"Nassiri","year":"2013","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.jtct.2021.06.001_bib0159","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41409-018-0090-z","article-title":"Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation","volume":"53","author":"Pathak","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0160","doi-asserted-by":"crossref","first-page":"13827","DOI":"10.1073\/pnas.1609118113","article-title":"Graft versus self (GvS) against T-cell autoantigens is a mechanism of graft-host interaction","volume":"113","author":"Mirza","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtct.2021.06.001_bib0161","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000439490","article-title":"Retinal involvement in a patient with cerebral manifestation of chronic graft-versus-host-disease","volume":"38","author":"Blecha","year":"2015","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.jtct.2021.06.001_bib0162","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jtos.2016.04.003","article-title":"Superior limbic keratoconjunctivitis-like inflammation in patients with chronic graft-versus-host disease","volume":"14","author":"Sivaraman","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtct.2021.06.001_bib0163","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ajo.2018.02.020","article-title":"Subtarsal fibrosis is associated with ocular surface epitheliopathy in graft-versus-host disease","volume":"189","author":"Kheirkhah","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0164","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jtos.2017.08.002","article-title":"Conjunctival subepithelial fibrosis and meibomian gland atrophy in ocular graft-versus-host disease","volume":"15","author":"Kusne","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtct.2021.06.001_bib0165","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.2147\/OPTH.S51180","article-title":"Bilateral corneal ulceration in ocular graft-versus-host disease","volume":"7","author":"Stevenson","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0166","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/sj.eye.6702589","article-title":"Corneal grafting and aggressive medication for corneal defects in graft-versus-host disease following bone marrow transplantation","volume":"21","author":"Tarnawska","year":"2007","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jtct.2021.06.001_bib0167","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/bjo.77.8.525","article-title":"Penetrating keratoplasty in severe ocular graft versus host disease","volume":"77","author":"Heath","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0168","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-0042-123148","article-title":"Osteo-odonto-keratoprosthesis in severe ocular graft versus host disease","volume":"234","author":"Plattner","year":"2017","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.jtct.2021.06.001_bib0169","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1038\/srep03419","article-title":"International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I)","volume":"3","author":"Ogawa","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtct.2021.06.001_bib0170","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0171","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00277-015-2575-9","article-title":"Verification of the new grading scale for ocular chronic graft-versus-host disease developed by the German-Austrian-Swiss consensus conference on chronic GVHD","volume":"95","author":"Blecha","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0172","first-page":"797","article-title":"Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation","volume":"18","author":"Riemens","year":"2012","journal-title":"Mol Vis"},{"key":"10.1016\/j.jtct.2021.06.001_bib0173","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jtos.2019.12.005","article-title":"Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD)","volume":"18","author":"Hu","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtct.2021.06.001_bib0174","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1167\/iovs.13-12844","article-title":"Tear fluid extracellular DNA: diagnostic and therapeutic implications in dry eye disease","volume":"54","author":"Tibrewal","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtct.2021.06.001_bib0175","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1167\/iovs.12-10430","article-title":"Ocular surface extracellular DNA and nuclease activity imbalance: a new paradigm for inflammation in dry eye disease","volume":"53","author":"Sonawane","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtct.2021.06.001_bib0176","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jtos.2018.11.001","article-title":"A novel and innovative paper-based analytical device for assessing tear lactoferrin of dry eye patients","volume":"17","author":"Sonobe","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtct.2021.06.001_bib0177","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/ICO.0000000000001411","article-title":"Functional role of lacrimal gland fibroblasts in a mouse model of chronic graft-versus-host disease","volume":"37","author":"Yamane","year":"2018","journal-title":"Cornea"},{"key":"10.1016\/j.jtct.2021.06.001_bib0178","doi-asserted-by":"crossref","first-page":"10778","DOI":"10.1096\/fj.201900218R","article-title":"Senescence-associated secretory phenotype promotes chronic ocular graft-versus-host disease in mice and humans","volume":"34","author":"Yamane","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.jtct.2021.06.001_bib0179","doi-asserted-by":"crossref","first-page":"e09394","DOI":"10.7554\/eLife.09394","article-title":"MHC-compatible bone marrow stromal\/stem cells trigger fibrosis by activating host T cells in a scleroderma mouse model","volume":"5","author":"Ogawa","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.jtct.2021.06.001_bib0180","doi-asserted-by":"crossref","first-page":"41939","DOI":"10.1038\/srep41939","article-title":"Novel treatment of chronic graft-versus-host disease in mice using the ER stress reducer 4-phenylbutyric acid","volume":"7","author":"Mukai","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtct.2021.06.001_bib0181","doi-asserted-by":"crossref","first-page":"e64724","DOI":"10.1371\/journal.pone.0064724","article-title":"Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease","volume":"8","author":"Yaguchi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2021.06.001_bib0182","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.2353\/ajpath.2009.090318","article-title":"Epithelial mesenchymal transition in human ocular chronic graft-versus-host disease","volume":"175","author":"Ogawa","year":"2009","journal-title":"The American journal of pathology"},{"key":"10.1016\/j.jtct.2021.06.001_bib0183","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1167\/iovs.05-0227","article-title":"Donor fibroblast chimerism in the pathogenic fibrotic lesion of human chronic graft-versus-host disease","volume":"46","author":"Ogawa","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtct.2021.06.001_bib0184","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbmt.2016.07.012","article-title":"Novel scoring criteria for the evaluation of ocular graft-versus-host disease in a preclinical allogeneic hematopoietic stem cell transplantation animal model","volume":"22","author":"Perez","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0185","first-page":"743","article-title":"Ocular diseases and epithelial mesenchymal transition","volume":"120","author":"Ogawa","year":"2016","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.jtct.2021.06.001_bib0186","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.exer.2016.11.004","article-title":"Assessment of dry eye in a GVHD murine model: approximation through tear osmolarity measurement","volume":"154","author":"Martinez-Carrasco","year":"2017","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtct.2021.06.001_bib0187","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1167\/iovs.14-15630","article-title":"Recruitment of donor T cells to the eyes during ocular GVHD in recipients of MHC-matched allogeneic hematopoietic stem cell transplants","volume":"56","author":"Herretes","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtct.2021.06.001_bib0188","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/ICO.0000000000001487","article-title":"Ocular surface and tear film characteristics in a sclerodermatous chronic graft-versus-host disease mouse model","volume":"37","author":"He","year":"2018","journal-title":"Cornea"},{"key":"10.1016\/j.jtct.2021.06.001_bib0189","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1167\/iovs.05-0040","article-title":"Lacrimal gland involvement in graft-versus-host disease: a murine model","volume":"46","author":"Hassan","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtct.2021.06.001_bib0190","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1182\/bloodadvances.2018028431","article-title":"Ocular instillation of vitamin A-coupled liposomes containing HSP47 siRNA ameliorates dry eye syndrome in chronic GVHD","volume":"3","author":"Ohigashi","year":"2019","journal-title":"Blood advances"},{"key":"10.1016\/j.jtct.2021.06.001_bib0191","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.3389\/fimmu.2018.03104","article-title":"BET bromodomain inhibitors which permit treg function enable a combinatorial strategy to suppress GVHD in pre-clinical allogeneic HSCT","volume":"9","author":"Copsel","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0192","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1167\/iovs.19-27843","article-title":"Graft versus host disease-associated dry eye: role of ocular surface mucins and the effect of rebamipide, a mucin secretagogue","volume":"60","author":"Shamloo","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtct.2021.06.001_bib0193","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1096\/fj.201700176R","article-title":"Inhibition of vascular adhesion protein-1 for treatment of graft-versus-host disease in mice","volume":"32","author":"Mukai","year":"2018","journal-title":"FASEB J"},{"issue":"19","key":"10.1016\/j.jtct.2021.06.001_bib0194","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122430","article-title":"SYK inhibitor entospletinib prevents ocular and skin GVHD in mice","volume":"3","author":"Poe","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtct.2021.06.001_bib0195","doi-asserted-by":"crossref","first-page":"e87001","DOI":"10.1172\/jci.insight.87001","article-title":"Aldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring","volume":"1","author":"Ahadome","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtct.2021.06.001_bib0196","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4939-7896-0_5","article-title":"Induction and characterization of the allergic eye disease mouse model","volume":"1799","author":"Reyes","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0197","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/bmt.2014.242","article-title":"Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD","volume":"50","author":"Frey Tirri","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0198","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2012-05-393389","article-title":"How we treat oral chronic graft-versus-host disease","volume":"120","author":"Treister","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0199","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bmt.2008.297","article-title":"Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT","volume":"43","author":"Oda","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0200","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0201","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3389\/fimmu.2020.02017","article-title":"Autoimmunity following allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Buxbaum","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0202","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/bmt.2015.105","article-title":"Chronic GvHD-associated serositis and pericarditis","volume":"50","author":"Leonard","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0203","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/pon.3159","article-title":"Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study","volume":"22","author":"Scherwath","year":"2013","journal-title":"Psychooncology"},{"key":"10.1016\/j.jtct.2021.06.001_bib0204","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2012-09-456590","article-title":"The central nervous system is a target of acute graft versus host disease in mice","volume":"121","author":"Hartrampf","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0205","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1172\/JCI130272","article-title":"Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia","volume":"130","author":"Mathew","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2021.06.001_bib0206","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/blood-2014-01-547612","article-title":"CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis","volume":"123","author":"Kaliyaperumal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0207","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/bmt.2014.29","article-title":"Acute disseminated encephalomyelitis following allo-SCT: central nervous system manifestation of GVHD","volume":"49","author":"Harvey","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0208","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/brain\/awq245","article-title":"Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease","volume":"133","author":"Grauer","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jtct.2021.06.001_bib0209","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/bmt.2009.312","article-title":"Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye","volume":"45","author":"Wang","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0210","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/labinvest.3700541","article-title":"CD95 ligand-dependent endothelial cell death initiates oral mucosa damage in a murine model of acute graft versus host disease","volume":"87","author":"Deschaumes","year":"2007","journal-title":"Lab Invest"},{"key":"10.1016\/j.jtct.2021.06.001_bib0211","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood.V99.8.2940","article-title":"CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications","volume":"99","author":"Janin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0212","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/01.STR.0000125865.01546.bb","article-title":"Cerebral endothelial expression of adhesion molecules in mice with chronic graft-versus-host disease","volume":"35","author":"Sostak","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jtct.2021.06.001_bib0213","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(02)08907-9","article-title":"Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease","volume":"359","author":"Biedermann","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2021.06.001_bib0214","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1182\/blood-2013-03-488148","article-title":"Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation","volume":"122","author":"Tardieu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0215","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2006-10-054080","article-title":"Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation","volume":"110","author":"Tichelli","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0216","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbmt.2016.10.011","article-title":"Late complications and quality of life after reduced-intensity conditioning allogeneic stem cell transplantation","volume":"23","author":"Clavert","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0217","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fpsyg.2017.00253","article-title":"A review of demographic, medical, and treatment variables associated with health-related quality of life (HRQOL) in survivors of hematopoietic stem cell (HSCT) and bone marrow transplantation (BMT) during childhood","volume":"8","author":"Reinfjell","year":"2017","journal-title":"Front Psychol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0218","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1182\/bloodadvances.2019001126","article-title":"Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia","volume":"4","author":"Lee","year":"2020","journal-title":"Blood advances"},{"key":"10.1016\/j.jtct.2021.06.001_bib0219","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/cncr.31781","article-title":"Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: a report from the Center for International Blood and Marrow Transplant Research (CIBMTR)","volume":"125","author":"Bhatt","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2021.06.001_bib0220","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.bbmt.2014.05.001","article-title":"Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease","volume":"20","author":"El-Jawahri","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0221","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.bbmt.2018.01.024","article-title":"Superior survival of black versus white patients following post-transplant cyclophosphamide-based haploidentical transplantation for adults with hematologic malignancy","volume":"24","author":"Solomon","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0222","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100674","article-title":"Follow-up issues in survivors of hematologic malignancies\u2014current stance and future perspectives","volume":"44","author":"Muhsen","year":"2020","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2021.06.001_bib0223","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41409-019-0748-1","article-title":"Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults","volume":"55","author":"Majhail","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0224","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.bbmt.2015.03.020","article-title":"National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0225","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/bmj.311.7020.1621","article-title":"Clinical trials and rare diseases: a way out of a conundrum","volume":"311","author":"Lilford","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.jtct.2021.06.001_bib0226","first-page":"2118","article-title":"The ethics of underpowered clinical trials","volume":"288","author":"Janosky","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2021.06.001_bib0227","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1089\/hum.2011.2515","article-title":"Orphan drugs, big pharma","volume":"22","author":"Philippidis","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jtct.2021.06.001_bib0228","unstructured":"Administration FaD. Rare Diseases: Common Issues in Drug Development. In: FDA, ed2019."},{"key":"10.1016\/j.jtct.2021.06.001_bib0229","unstructured":"Administration FaD. Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products. In: FDA, ed2019."},{"key":"10.1016\/j.jtct.2021.06.001_bib0230","unstructured":"Administration FaD. BEST (Biomarker, Endpoints, and other Tools) Resource. In: FDA, ed2020."},{"key":"10.1016\/j.jtct.2021.06.001_bib0231","unstructured":"Administration FaD. Rare Diseases: Natural History Studies for Drug Development. In: FDA, ed2019."},{"key":"10.1016\/j.jtct.2021.06.001_bib0232","unstructured":"Administration FaD. Adaptive Designs for Clinical Trials of Drugs and Biologics. In: FDA, ed2019."},{"key":"10.1016\/j.jtct.2021.06.001_bib0233","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrclinonc.2011.165","article-title":"Adaptive clinical trials in oncology","volume":"9","author":"Berry","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0234","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.molonc.2015.02.011","article-title":"The brave new world of clinical cancer research: Adaptive biomarker-driven trials integrating clinical practice with clinical research","volume":"9","author":"Berry","year":"2015","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0235","unstructured":"Administration FaD. Guidance for the use of Bayesian statistics in medical device clinical trials. In: FDA, ed2010."},{"key":"10.1016\/j.jtct.2021.06.001_bib0236","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/art.39501","article-title":"The American College of Rheumatology Provisional Composite Response Index for clinical trials in early diffuse cutaneous systemic sclerosis","volume":"68","author":"Khanna","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0237","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1111\/j.1600-0846.2012.00659.x","article-title":"Assessment of chronic sclerodermoid Graft-versus-Host Disease patients, using 20 MHz high-frequency ultrasonography and cutometer methods","volume":"19","author":"Osmola-Ma\u0144kowska","year":"2013","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0238","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.ultrasmedbio.2015.06.007","article-title":"Preliminary results on the feasibility of using ARFI\/SWEI to assess cutaneous sclerotic diseases","volume":"41","author":"Lee","year":"2015","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0239","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.ultrasmedbio.2020.01.021","article-title":"Ultrasound surface wave elastography for assessing scleroderma","volume":"46","author":"Zhang","year":"2020","journal-title":". Ultrasound in medicine & biology"},{"issue":"4","key":"10.1016\/j.jtct.2021.06.001_bib0240","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jid.2020.07.031","article-title":"Quantifying skin stiffness in graft-versus-host disease, morphea, and systemic sclerosis using acoustic radiation force impulse imaging and shear wave elastography","volume":"141","author":"Cardones","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0241","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1182\/blood-2019-129125","article-title":"Interobserver reproducibility of the myoton and durometer devices to measure skin stiffness and hardness in chronic cutaneous graft-versus-host disease patients","volume":"134","author":"Chen","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0242","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2214\/AJR.08.1699","article-title":"Musculocutaneous chronic graft-versus-host disease: MRI follow-up of patients undergoing immunosuppressive therapy","volume":"192","author":"Horger","year":"2009","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0243","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1097\/RLU.0b013e3182816559","article-title":"Imaging findings and therapy response monitoring in chronic sclerodermatous graft-versus-host disease: preliminary data of a simultaneous PET\/MRI approach","volume":"38","author":"Sauter","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jtct.2021.06.001_bib0244","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/lsm.22788","article-title":"Optical coherence tomography angiography of normal skin and inflammatory dermatologic conditions","volume":"50","author":"Deegan","year":"2018","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jtct.2021.06.001_bib0245","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1055\/s-0029-1222575","article-title":"[Sclerodermiform chronic graft-versus-host disease after allogenic peripheral blood stem-cell transplantation]","volume":"134","author":"Neid","year":"2009","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jtct.2021.06.001_bib0246","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/j.jid.2020.03.883","article-title":"867 Direct mechanical measurements of skin to quantify evolution of sclerotic disease","volume":"140","author":"Baker","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0247","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41409-018-0346-7","article-title":"Non-invasive measurement of sclerosis in cutaneous cGVHD patients with the handheld device Myoton: a cross-sectional study","volume":"54","author":"Chen","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0248","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-2600(19)30262-0","article-title":"Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"8","author":"Richeldi","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jtct.2021.06.001_bib0249","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13075-017-1356-3","article-title":"Anti-connective tissue growth factor (CTGF\/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis","volume":"19","author":"Makino","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jtct.2021.06.001_bib0250","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1002\/art.39797","article-title":"An autotaxin\/lysophosphatidic acid\/interleukin-6 amplification loop drives scleroderma fibrosis","volume":"68","author":"Castelino","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0251","first-page":"PA881","article-title":"Late breaking abstract - ND-L02-s0201 treatment leads to efficacy in preclinical IPF models","volume":"50","author":"Zabludoff","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtct.2021.06.001_bib0252","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1167\/iovs.06-0601","article-title":"Role of heat shock protein 47, a collagen-binding chaperone in Lacrimal Gland Pathology in Patients with cGVHD","volume":"48","author":"Ogawa","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtct.2021.06.001_bib0253","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3389\/fimmu.2018.02328","article-title":"The development of serum amyloid P as a possible therapeutic","volume":"9","author":"Pilling","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0254","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1182\/blood-2018-99-115362","article-title":"PRM-151 in myelofibrosis: efficacy and safety in an open label extension study","volume":"132","author":"Verstovsek","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0255","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bcp.2018.07.047","article-title":"EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis","volume":"157","author":"Garcia-Martin","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"10.1016\/j.jtct.2021.06.001_bib0256","doi-asserted-by":"crossref","first-page":"e92281","DOI":"10.1172\/jci.insight.92281","article-title":"Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis","volume":"2","author":"Cinar","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtct.2021.06.001_bib0257","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1002\/art.27642","article-title":"Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis","volume":"62","author":"Marquart","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtct.2021.06.001_bib0258","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/bcp.13669","article-title":"In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody","volume":"84","author":"Reid","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jtct.2021.06.001_bib0259","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/03008207.2018.1500558","article-title":"Oncostatin M and its role in fibrosis","volume":"60","author":"Stawski","year":"2019","journal-title":"Connect Tissue Res"},{"key":"10.1016\/j.jtct.2021.06.001_bib0260","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/annrheumdis-2020-eular.1753","article-title":"THU0329\u2005safety, target engagement, and initial efficacy of AVID200, a first-in-class potent and isoform-selective inhibitor of TGF-beta 1 and 3, in patients with diffuse cutaneous systemic sclerosis (DCSSC): a phase 1 dose escalation study","volume":"79","author":"Lafyatis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2021.06.001_bib0261","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/annrheumdis-2018-213031","article-title":"Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis","volume":"77","author":"Denton","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2021.06.001_bib0262","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","article-title":"Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis","volume":"71","author":"Khan","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2021.06.001_bib0263","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.bbmt.2011.07.001","article-title":"Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease","volume":"17","author":"Drobyski","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.06.001_bib0264","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood-2015-10-678706","article-title":"Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism","volume":"127","author":"Flynn","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0265","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.06.001_bib0266","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtct.2021.06.001_bib0267","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1182\/blood-2002-06-1813","article-title":"Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants","volume":"102","author":"Freudenberger","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.06.001_bib0268","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/RCT.0b013e31825ba274","article-title":"Organizing pneumonia in recipients of hematopoietic stem cell transplantation: CT features in 16 patients","volume":"36","author":"Pipavath","year":"2012","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.jtct.2021.06.001_bib0269","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41409-019-0636-8","article-title":"Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Bondeelle","year":"2020","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721009490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721009490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:07:09Z","timestamp":1763003229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721009490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":269,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2666636721009490"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.06.001","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}